IRF7 and lung carcinoma: In order to revive the disabled IFN response in lung cancer cells, IRF5 and IRF7 alone or in combination were stably transfected into CRL5810 cells, in which sustained 5-aza-dC treatment had no effect on demethylation of IRF promoter.